Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam to Sell $125M in Stock
January 17, 2013
Alnylam to Sell $125M in Stock
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More
May 21, 2013 / Gene Silencing News
Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13
May 16, 2013 / Gene Silencing News
Alnylam Loses Cubist as RSV Partner, Stays Focused on ATTR Programs
February 14, 2013 / Gene Silencing News
Alnylam, Tekmira Shares Regain Lost Ground Heading into 2013
January 24, 2013 / Gene Silencing News
Oligo Drugs Advance in the Clinic in 2012 as Delivery Hurdles are Addressed
January 3, 2013 / Gene Silencing News